115 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
accounting rules;
persons who hold or receive the Common Stock pursuant to the exercise of any employee stock option or otherwise as compensation
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the board of directors of the Company … or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, and (D
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders
8-K
EX-4.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders
424B3
9qarcz rise
2 Feb 24
Prospectus supplement
12:00am
8-K
EX-4.1
qhm5ormtc3caiic3zki1
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
guv6uwxppekgfvt72
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
ghzartln7
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
xqdp qyhwp
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
5nvamsoeqk lxu3
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
0zz gqthxx
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
fn5s h4mkvx
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
txcld xkbvlx
2 Nov 23
Prospectus supplement with pricing info
9:00am